logo

For the Inventor, By the Inventor

Berkeley, CA, United States of America

R Glenn Hammonds, Jr

This inventor holds 11 USPTO granted patents. Top assignees: Genentech, Inc., Exelixis, Inc., The University of Melbourne. Active years: 1986-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: R Glenn Hammonds, Jr. Retrieved from https://idiyas.com/inventor/r-glenn-hammonds-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 3.9

ph-index = 7

Forward Citations = 294(Granted Patents)


Location History:

  • San Francisco, CA (US) (1986 - 1991)
  • Oakland, CA (US) (1997)
  • Berkeley, CA (US) (1992 - 2003)

Company Filing History:

goldMedal8 out of 3,299 
 
Genentech, Inc.
 patents
silverMedal1 out of 177 
 
Exelixis, Inc.
 patents
bronzeMedal1 out of 330 
 
The University of Melbourne
 patents
4. 1 out of 16,025 
 
University of California
 patents
5. 1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1986-2003

Loading Chart...
11 patents (USPTO):Explore Patents
1. 6599717 - Invertebrate vascular endothelial growth factor receptor (2003-07-29),
2. 6255068 - Variant gas6 polypeptides (2001-07-03),
3. 6211142 - Compositions comprising gas6 polypeptides and articles of manufacture comprising the same (2001-04-03),
4. 6169070 - Mer receptor activation by gas6 (2001-01-02),
5. 5955420 - Rse receptor activation (1999-09-21),
6. 5688763 - Compositions and methods for the synthesis of growth hormone receptor (1997-11-18),
7. 5688760 - Polypeptides having bone resorption inhibitory activity comprising (1997-11-18),
8. 5168050 - Mammalian expression of the bone morphogenetic protein-2B using (1992-12-01),
9. 5057417 - Compositions and methods for the synthesis of growth hormone receptor (1991-10-15),
10. 4857637 - Methods and compositions for immunologically modulating growth hormone (1989-08-15),
11. 4624944 - Human seminal alpha-inhibins (1986-11-25),

Title: R Glenn Hammonds, Jr: A Pioneer in Innovations and Patents

Introduction:

R Glenn Hammonds, Jr, based in Berkeley, CA (US), is a distinguished inventor whose passion for innovation and dedication to excellence have solidified his reputation as a pioneering figure in the realm of patents and inventions.

Latest Patents:

With a remarkable portfolio consisting of 11 patents, R Glenn Hammonds, Jr's most recent inventions include groundbreaking technologies such as the Invertebrate Vascular Endothelial Growth Factor Receptor and Variant Gas6 Polypeptides. These patents showcase his ingenuity in genetic modification and protein activation.

Career Highlights:

Having worked with esteemed companies like Genentech, Inc., R Glenn Hammonds, Jr has demonstrated his expertise in the field of biotechnology and pharmaceuticals. His contributions have significantly advanced research and development efforts in these industries, making him a valuable asset in the scientific community.

Collaborations:

Throughout his career, R Glenn Hammonds, Jr has collaborated with visionary individuals such as Paul J Godowski and Melanie Rose Mark. Together, they have synergized their strengths to drive innovation, leading to the successful development of novel technologies and solutions.

Conclusion:

In conclusion, R Glenn Hammonds, Jr's relentless pursuit of innovation and his commitment to excellence have established him as a trailblazer in the world of patents and inventions. His groundbreaking work continues to inspire future generations of inventors and researchers to push the boundaries of technological advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…